Literature DB >> 20331356

Generation of functional hepatocytes from mouse germ line cell-derived pluripotent stem cells in vitro.

Sharmila Fagoonee1, Robin M Hobbs, Letizia De Chiara, Daniela Cantarella, Rosario M Piro, Emanuela Tolosano, Enzo Medico, Paolo Provero, Pier Paolo Pandolfi, Lorenzo Silengo, Fiorella Altruda.   

Abstract

Germ line cell-derived pluripotent stem cells (GPSCs) are similar to embryonic stem (ES) cells in that they can proliferate intensively and differentiate into a variety of cell types. Previous studies have revealed some inherent differences in gene expression between undifferentiated mouse ES cells and GPSCs. Our aims were to generate functional hepatocytes from mouse GPSCs in vitro and to investigate whether the differences in gene expression may impact on the hepatocyte differentiation capacity of the GPSCs compared with ES cells. Mouse GPSCs and ES cells were induced to differentiate into hepatocytes through embryoid body formation, with very high efficiency. These hepatocytes were characterized at cellular, molecular, and functional levels. The GPSC-derived hepatocytes expressed hepatic markers and were metabolically active as shown by albumin and haptoglobin secretion, urea synthesis, glycogen storage, and indocyanine green uptake. We also performed an unprecedented DNA microarray analysis comparing different stages of hepatocyte differentiation. Gene expression profiling demonstrated a strong similarity between GPSC and ES cells at different stages of induced hepatic differentiation. Moreover, Pearson correlation analysis of the microarray datasets suggested that, at late hepatic differentiation stages, the in vitro-derived cells were closer to fetal mouse primary hepatocytes than to those obtained from neonates. We have shown for the first time that adult GPSCs can be induced to differentiate into functional hepatocytes in vitro. These GPSC-derived hepatocytes offer great potential for cell replacement therapy for a wide variety of liver diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20331356     DOI: 10.1089/scd.2009.0496

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  11 in total

Review 1.  Potential applications of germline cell-derived pluripotent stem cells in organ regeneration.

Authors:  Sharmila Fagoonee; Rinaldo Pellicano; Lorenzo Silengo; Fiorella Altruda
Journal:  Organogenesis       Date:  2011-04-01       Impact factor: 2.500

2.  Efficient generation of hepatic cells from multipotent adult mouse germ-line stem cells using an OP9 co-culture system.

Authors:  Katrin Streckfuss-Bömeke; Jörg Jende; I-Fen Cheng; Gerd Hasenfuss; Kaomei Guan
Journal:  Cell Reprogram       Date:  2013-12-31       Impact factor: 1.987

3.  RNA-binding proteins in pluripotency, differentiation, and reprogramming.

Authors:  Diana Guallar; Jianlong Wang
Journal:  Front Biol (Beijing)       Date:  2014-10

4.  Renal cells from spermatogonial germline stem cells protect against kidney injury.

Authors:  Letizia De Chiara; Sharmila Fagoonee; Andrea Ranghino; Stefania Bruno; Giovanni Camussi; Emanuela Tolosano; Lorenzo Silengo; Fiorella Altruda
Journal:  J Am Soc Nephrol       Date:  2013-10-17       Impact factor: 10.121

5.  The RNA binding protein ESRP1 fine-tunes the expression of pluripotency-related factors in mouse embryonic stem cells.

Authors:  Sharmila Fagoonee; Claudia Bearzi; Ferdinando Di Cunto; John G Clohessy; Roberto Rizzi; Markus Reschke; Emanuela Tolosano; Paolo Provero; Pier Paolo Pandolfi; Lorenzo Silengo; Fiorella Altruda
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

6.  Future research and therapeutic applications of human stem cells: general, regulatory, and bioethical aspects.

Authors:  Antonio Liras
Journal:  J Transl Med       Date:  2010-12-10       Impact factor: 5.531

7.  Mulcom: a multiple comparison statistical test for microarray data in Bioconductor.

Authors:  Claudio Isella; Tommaso Renzulli; Davide Corà; Enzo Medico
Journal:  BMC Bioinformatics       Date:  2011-09-28       Impact factor: 3.307

8.  JMJD3 aids in reprogramming of bone marrow progenitor cells to hepatic phenotype through epigenetic activation of hepatic transcription factors.

Authors:  Veena Kochat; Zaffar Equbal; Prakash Baligar; Vikash Kumar; Madhulika Srivastava; Asok Mukhopadhyay
Journal:  PLoS One       Date:  2017-03-22       Impact factor: 3.240

9.  Long Term Liver Engraftment of Functional Hepatocytes Obtained from Germline Cell-Derived Pluripotent Stem Cells.

Authors:  Sharmila Fagoonee; Elvira Smeralda Famulari; Lorenzo Silengo; Emanuela Tolosano; Fiorella Altruda
Journal:  PLoS One       Date:  2015-08-31       Impact factor: 3.240

Review 10.  Evolving Cell-Based and Cell-Free Clinical Strategies for Treating Severe Human Liver Diseases.

Authors:  Viviana Cernigliaro; Rossella Peluso; Beatrice Zedda; Lorenzo Silengo; Emanuela Tolosano; Rinaldo Pellicano; Fiorella Altruda; Sharmila Fagoonee
Journal:  Cells       Date:  2020-02-07       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.